Skip to main content

25 December 2025

Last updated: Wednesday 24 December 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A good beginning in the perilous biotech business

Tuesday 26 October 2010

Interviewee/Contributor

Ingmar Hoerr

Organisation

CureVac GmbH

Organisations

Cellectis SA
VectorY Therapeutics BV
Virttu Biologics Ltd
Consultant
Sofinnova Partners
Nextech Invest Ltd
Abivax SA
C4X Discovery Ltd
European Biopharmaceutical Enterprises
ISA Pharmaceuticals BV

Interviewees and Contributers

Neelam Patel
Frank Carr
Philipp Spycher
David Moller
Tony Woodgate
Christian Rohlff
Florian Bazant-Hegemark
Neil Clark and William Love
Yasmin de Faria Krim
Morten Grunnet

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form